Fact CheckerSign in

NCT04252781Recruiting

Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)

Source: ClinicalTrials.gov · Last updated 9 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Chronic Obstructive Pulmonary Disease (COPD), , secondary to smoking, is a major public health issue with very high direct and indirect costs. The impact on the health system of undiagnosed patients, up to 70% of patients, is increasingly documented. However, systematic spirometry screening remains controversial among smokers in the absence of data to link the detection of new patients with improved management and clinical events and health goals. More generally, there is little data on the evolution of patients in real life once they have entered the care system. The premise is that with systematic screening in general medicine, it is possible to identify the evolution of newly diagnosed COPD patients, to distinguish the different possible evolutions according to the initial phenotype and the management.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
6 Jan 2020
Start date
20 Aug 2020
Primary completion date
7 Jan 2025
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Diseases
COPD
NCT number
NCT04252781

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 20 Aug 2020 to the primary completion date, 7 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cancer being treated

Other

  • Known COPD
  • No affiliation to the social security or other social protection scheme
  • Pregnant or lactating woman
  • Patient deprived of liberty or under legal protection (under tutorship or curatorship

Who the study is looking for

  • Age\> 35 years
  • Smoking \> 20 PA
  • Active smoking (cessation \< 1 month)
  • Signature of consent to participate in Phase I of the study
  • FEV1 / FVC \<70% of the theoretical value and / or \<LLN (Lower limit of normal)
  • Signature of consent to participate in Phase II of the study

Age in the registry: 35 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hopital Henri Mondor
Coordinator of this site? Confirm its status
CréteilFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.